Consonance Capital Management LP 13D and 13G filings for Aurinia Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-17 2:22 pm Sale |
2020-12-31 | 13G | Aurinia Pharmaceuticals Inc. AUPH |
Consonance Capital Management LP | 0 0.000% |
-6,058,505 (Position Closed) |
Filing |
| 2021-02-16 2:19 pm Sale |
2020-12-31 | 13G | Aurinia Pharmaceuticals Inc. AUPH |
Consonance Capital Management LP | 6,058,505 11.000% |
-567,166 (-8.56%) |
Filing |